Covid-19: WHO supports the use of Oxford vaccine 'even against variants'

World Health Organization (WHO) has recommended using vaccine developed by University of Oxford and AstraZeneca, even for countries who are battling new variants of coronavirus. organisation furr said that vaccine could be used in people d over 65. Seen as ‘vaccine of world’, vaccine is cheap and can be mass produced and stored in a standard fridge. 

This comes in response to a report that alleged that AstraZeneca vaccines were less effective against mutant of coronavirus first detected in South Africa. WHO Strategic visory Group of Experts on Immunization (S) has found out that vaccine is effective against South African variant. 

Re: COVID-19: 'Don't Rely Too Much On US Intel', Says Member Of Special WHO Mission To China

A vital part 

AstraZeneca vaccine is currently a vital part of WHO-sponsored Covax programme which was set up in order to procure COVID-19 vaccines and ensure ir equitable distribution across globe in fight against pandemic. Oxford-AstraZeneca's COVID-19 vaccine candidate reportedly amounts for all of 337.2 million vaccine doses Covax is preparing to ship to around 145 nations during first half of 2021 after it received WHO authorisation. As per reports, it is expected next week. Tedros ted that AstraZeneca prevents severe COVID-19 illness, hospitalisation and sometimes death.

Re: WHO Cautions Against 'long COVID', Says 'don't Let It Fall Through Cracks'

Earlier, organisation said that it was "too early to be dismissing" AstraZeneca COVID-19 vaccine and regarded it still as an essential tool to tackle pandemic after South Africa delayed its immunisation programme. While WHO chief called delaying of iculation in South Africa as a "concerning news", he of Coalition for Epidemic Preparedness Invations (CEPI), which co-les Covax vaccine facility Richard Hatchett said it was "too early" to suspend vaccine. 

Re: Harris: Vital WH Is Relevant In Fighting COVID

Also Re: Inside Tunisia Hospital Treating COVID Patients

(Im Credits: AP/Oxford/Twitter)